Subtype
Malignant Uterine Neoplasm
CI-CAN-00005955Explore in graph →
824 active trials7 approved drugs44 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00005955Explore in graph →
Clinical trials
3,291 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (333)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00285415 | A Phase II Evaluation of Docetaxel and Carboplatin Followed by Tumor Volume Directed Pelvic Irradiation | terminated | Phase 2 | 46 | Carilion ClinicOTHER | 1 | Feb 5, 2021 | clinicaltrials |
| NCT00506779 | Gleevec/Taxol for Patients With Uterine Papillary Serous Carcinoma | terminated | Phase 1 / Phase 2 | 17 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 18, 2020 | clinicaltrials |
| NCT00503581 |
| Megestrol in Treating Patients With Endometrial Neoplasia or Endometrial Hyperplasia |
| terminated |
| Phase 2 |
| 9 |
| Gynecologic Oncology GroupNETWORK |
| 1 |
| Nov 3, 2020 |
| clinicaltrials |
| NCT03423082 | Pilot Study to Assess the Potential Clinical Utility of 18F Fluciclovine PET for Cervical and Endometrial Cancer. | terminated | Phase 4 | 1 | Nghi NguyenOTHER | 1 | Oct 28, 2020 | clinicaltrials |
| NCT02425878 | Ulipristal Acetate 10 mg and Asisted Reproduction | terminated | Phase 3 | 2 | Instituto Valenciano de Infertilidad, IVI VALENCIAOTHER | 1 | Oct 14, 2020 | clinicaltrials |
| NCT02476955 | Open-label Phase 1b Study of ARQ 092 in Combination With Anastrozole | terminated | Phase 1 | 41 | ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)INDUSTRY | 1 | Sep 30, 2020 | clinicaltrials |
| NCT01939028 | Lymph Node Mapping in Patients With Newly Diagnosed Endometrial Cancer Undergoing Surgery | terminated | N/A | 58 | Case Comprehensive Cancer CenterOTHER | 1 | Aug 27, 2020 | clinicaltrials |
| NCT02045433 | Stereotactic Body Radiation Therapy (SABR) for Definitive Treatment of Locally Advanced Cervical Cancer | terminated | Phase 2 | 16 | University of Texas Southwestern Medical CenterOTHER | 1 | Aug 21, 2020 | clinicaltrials |
| NCT01280045 | Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy | terminated | N/A | 5 | University of Sao PauloOTHER | 0 | Aug 13, 2020 | clinicaltrials |
| NCT01738724 | Study of the Efficacy of Dienogest in the Treatment of Uterine Leiomyomas When Compared to Desogestrel and Goserelin | terminated | Phase 4 | 14 | University of Sao PauloOTHER | 0 | Aug 13, 2020 | clinicaltrials |
| NCT02317302 | FDG Tumor Heterogeneity During Chemoradiation as a Predictor of Response in Patients With Cervical Cancer | terminated | Phase 1 | 48 | Washington University School of MedicineOTHER | 1 | Jun 11, 2020 | clinicaltrials |
| NCT03318107 | Ultrasound and Photoacoustic Imaging for Cervical Cancer | terminated | N/A | 2 | Washington University School of MedicineOTHER | 1 | May 29, 2020 | clinicaltrials |
| NCT01533207 | Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery | terminated | Phase 3 | 38 | Gynecologic Oncology GroupNETWORK | 8 | Apr 28, 2020 | clinicaltrials |
| NCT04132349 | Ulipristal Acetate in Symptomatic Uterine Fibroid | terminated | Phase 4 | 25 | Mỹ Đức HospitalOTHER | 1 | Apr 13, 2020 | clinicaltrials |
| NCT02665962 | Evaluating the Effect of Perioperative Caloric Restriction Program on Perioperative Outcomes in Patients With Obesity and Endometrial Cancer | terminated | N/A | 8 | Abramson Cancer Center at Penn MedicineOTHER | 1 | Mar 10, 2020 | clinicaltrials |
| NCT01392352 | HYPAZ: Hypertension Induced by Pazopanib(HYPAZ) | terminated | Phase 2 | 31 | Cambridge University Hospitals NHS Foundation TrustOTHER | 1 | Feb 13, 2020 | clinicaltrials |
| NCT03466034 | The Role of Hypoxia as a Selective Pressure for TP53 Mutations | terminated | — | 5 | Institute of Cancer Research, United KingdomOTHER | 1 | Jan 29, 2020 | clinicaltrials |
| NCT03852979 | Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility(NEOCON-F) | terminated | Phase 2 | 1 | The Netherlands Cancer InstituteOTHER | 1 | Jan 10, 2020 | clinicaltrials |
| NCT00394602 | Chemoradiation-Induced Nausea and Emesis: Quality of Life | terminated | — | 207 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT00519272 | A Prospective Study Examining the Barriers to Care for Harris County Cervical Cancer Patients | terminated | — | 200 | M.D. Anderson Cancer CenterOTHER | 1 | Jan 2, 2020 | clinicaltrials |
| NCT00924066 | Ixabepilone to Treat Cervical Cancer | terminated | Phase 2 | 41 | National Cancer Institute (NCI)NIH | 1 | Nov 21, 2019 | clinicaltrials |
| NCT00204997 | Preservation of Ovarian Function Via LOT in Squamous Cell Carcinoma of the Cervix | terminated | N/A | 10 | University of Wisconsin, MadisonOTHER | 1 | Nov 15, 2019 | clinicaltrials |
| NCT01583686 | CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer | terminated | Phase 1 / Phase 2 | 15 | National Cancer Institute (NCI)NIH | 1 | Oct 14, 2019 | clinicaltrials |
| NCT02566811 | Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)(STATEC) | terminated | N/A | 49 | University College, LondonOTHER | 1 | Sep 30, 2019 | clinicaltrials |
| NCT01834703 | Uterine Artery Embolization(UAE) Versus High-Intensity-Focused-Ultrasound(HIFU) for Treatment of Uterine Fibroids | terminated | N/A | 85 | Chinese University of Hong KongOTHER | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03210324 | A Study on the Mifepristone Tablets in the Treatment of Symptomatic Uterine Fibroids With Safety and Efficacy | terminated | Phase 4 | 434 | China Resources Zizhu Pharmaceutical Co., Ltd.INDUSTRY | 1 | Aug 7, 2019 | clinicaltrials |
| NCT03613493 | Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention | terminated | N/A | 175 | University of MiamiOTHER | 1 | Aug 2, 2019 | clinicaltrials |
| NCT00262821 | Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer | terminated | Phase 3 | 402 | National Cancer Institute (NCI)NIH | 2 | Jul 23, 2019 | clinicaltrials |
| NCT02811159 | An Extension Study of 12 mg Proellex® (Telapristone Acetate) Administered Orally in the Treatment of Premenopausal Women With Confirmed Symptomatic Uterine Fibroids | terminated | Phase 2 | 20 | Repros Therapeutics Inc.INDUSTRY | 1 | Jun 27, 2019 | clinicaltrials |
| NCT02558348 | Phase 1/2a Evaluation of AL3818 in Subjects With Recurrent or Metastatic Endometrial, Ovarian or Cervical Cancer (AL3818-US-001)(AL3818) | terminated | Phase 1 / Phase 2 | 12 | Advenchen Laboratories, LLCINDUSTRY | 1 | Jun 19, 2019 | clinicaltrials |
| NCT02153905 | T Cell Receptor Immunotherapy Targeting MAGE-A3 for Patients With Metastatic Cancer Who Are HLA-A*01 Positive | terminated | Phase 1 / Phase 2 | 3 | National Cancer Institute (NCI)NIH | 1 | Jun 17, 2019 | clinicaltrials |
| NCT01958112 | GSK1120212+GSK2141795 for Cervical Cancer | terminated | Phase 2 | 14 | Dana-Farber Cancer InstituteOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT02907073 | Positron Emission Tomography (PET) Imaging Studies With NIS Reporter | terminated | Phase 1 / Phase 2 | 8 | Mayo ClinicOTHER | 1 | May 17, 2019 | clinicaltrials |
| NCT02879058 | Intraoperative Ultrasound in Laparoscopic or Robotic Myomectomy Patients | terminated | N/A | 140 | The Cleveland ClinicOTHER | 1 | Mar 4, 2019 | clinicaltrials |
| NCT01251354 | Study of BN83495 in Post-menopausal Women With Endometrial Cancer Post-chemotherapy | terminated | Phase 2 | 6 | IpsenINDUSTRY | 2 | Jan 14, 2019 | clinicaltrials |
| NCT02868892 | A Study of Pemetrexed in Recurrent Cervical Adenocarcinomas | terminated | Phase 2 | 6 | Western Regional Medical CenterOTHER | 1 | Nov 2, 2018 | clinicaltrials |
| NCT02589366 | Lymphoseek as Lymphoid Tissue Targeting Agent in Patients With Cancer of the Endometrium | terminated | Phase 1 | 2 | University of California, San DiegoOTHER | 1 | Oct 15, 2018 | clinicaltrials |
| NCT00730886 | ExAblate Treatment of Uterine Fibroids for Fertility Enhancement | terminated | N/A | 2 | InSightecINDUSTRY | 1 | Aug 15, 2018 | clinicaltrials |
| NCT00084890 | Docetaxel and Carboplatin in Treating Patients With Recurrent Stage IVB Squamous Cell Carcinoma (Cancer) of the Cervix | terminated | Phase 1 | 15 | Wake Forest University Health SciencesOTHER | 1 | Aug 10, 2018 | clinicaltrials |
| NCT01197664 | Paricalcitol, Fluorouracil, and Radiation Therapy in Treating Patients With Rectal Cancer That Can Be Removed in Surgery | terminated | Phase 1 | 2 | Wake Forest University Health SciencesOTHER | 1 | Jul 2, 2018 | clinicaltrials |
| NCT00899093 | YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy | terminated | — | 2,500 | Gynecologic Oncology GroupNETWORK | 1 | May 22, 2018 | clinicaltrials |
| NCT01275664 | Granisetron, Aprepitant, and Dexamethasone in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy for Stage II, III, or IV Ovarian Cancer | terminated | N/A | 4 | Gynecologic Oncology GroupNETWORK | 1 | May 22, 2018 | clinicaltrials |
| NCT02412124 | Peer-to-Peer Support Program in Improving Quality of Life Outcomes in Patients With Gynecologic Cancer and Their Caregivers | terminated | N/A | 3 | City of Hope Medical CenterOTHER | 1 | May 11, 2018 | clinicaltrials |
| NCT02765698 | Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer | terminated | — | 2 | Mayo ClinicOTHER | 1 | Mar 27, 2018 | clinicaltrials |
| NCT02110953 | Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver | terminated | Phase 1 | 2 | Fox Chase Cancer CenterOTHER | 1 | Feb 26, 2018 | clinicaltrials |
| NCT00004261 | EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma | terminated | Phase 1 | — | University Health Network, TorontoOTHER | 1 | Feb 22, 2018 | clinicaltrials |
| NCT01934179 | Telomere Length in Predicting Toxicity in Older Patients With Stage III-IV Colorectal Cancer Undergoing Chemotherapy | terminated | — | 6 | Fox Chase Cancer CenterOTHER | 1 | Feb 7, 2018 | clinicaltrials |
| NCT00375804 | Racial Disparity in Endometrial Cancer | terminated | — | 43 | University of LouisvilleOTHER | 1 | Jan 9, 2018 | clinicaltrials |
| NCT01575444 | Cervical Cancer Screening Project Part C | terminated | — | 10 | University of MinnesotaOTHER | 1 | Dec 12, 2017 | clinicaltrials |
| NCT00278434 | Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3 | terminated | Phase 1 | 12 | University of California, San FranciscoOTHER | 1 | Nov 24, 2017 | clinicaltrials |
Data updated 23 days agoSource updated Feb 5, 2021source: clinicaltrials